Beta-Cell Function and Glycemic Control Following One-Year Vildagliptin Treatment, and after 12-Week Washout, in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia

被引：0
|
作者：
Bunck, Mathijs C.
Poelma, Marieke
Goede, Diane L.
Van Golen, Larissa W.
Van Genugten, Renate E.
Eekhoff, E. Marelise
Schweizer, Anja
Heine, Robert J.
Foley, James E.
Nijpels, Giel
Diamant, Michaela
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A17 / A17
页数：1
相关论文
共 40 条
  • [21] Sitagliptin monotherapy improved glycemic control in the fasting and postprandial states and beta-cell function after 24 weeks in patients with type 2 diabetes (T2DM)
    Aschner, Pablo
    Kipnes, Mark
    Lunceford, Jared
    Mickel, Carolyn
    Davies, Michael
    Williams-Herman, Debora
    DIABETES, 2006, 55 : A462 - A462
  • [22] Beta-cell function in treatment-naive patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials
    Blueher, Matthias
    Malhotra, Ankur
    Bader, Giovanni
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1403 - 1407
  • [23] Effect on beta cell function in newly diagnosed type 2 diabetes patients after treatment with vildagliptin and metformin: results from the VERIFY study
    Paldanius, P. M.
    Del Prato, S.
    Stumvoll, M.
    Matthews, D. R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S293 - S293
  • [24] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
  • [25] Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naive Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711-7)
    Patoulias, Dimitrios
    Doumas, Michael
    DIABETES & METABOLISM JOURNAL, 2019, 43 (06) : 906 - 908
  • [26] One year treatment with exenatide improves β cell function and glycaemic control in metformin treated type 2 diabetes patients
    Bunck, M. C.
    Diamant, M.
    Corner, A.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M.-R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    DIABETOLOGIA, 2007, 50 : S111 - S112
  • [27] Effects of dulaglutide and trelagliptin on beta cell function after one year in patients with type 2 diabetes: DUET-beta extension study
    Kondo, Y.
    Satoh, S.
    Terauchi, Y.
    DIABETOLOGIA, 2019, 62 : S379 - S380
  • [28] PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naive type 2 diabetes mellitus patients
    Liu, Xu
    Song, Ling
    Zhang, Yuanhui
    Li, Haiyan
    Cui, Cheng
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] Effect of Basal Insulin Plus Oral Antidiabetes Drug Therapy on beta-Cell Function and Glycaemic Control in Patients with Newly Diagnosed Type 2 Diabetes
    Mu, Pan-Wei
    Zeng, Long-Yi
    Chen, Yan-Ming
    Lu, Hong-Yun
    Wen, Xing-Qiao
    Zhang, Guo-Chao
    Xie, Ru-Ying
    Wang, Man-Man
    Shu, Jiong
    DIABETES, 2011, 60 : A288 - A288
  • [30] Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis
    Mortensen, Henrik B.
    Swift, Peter G. F.
    Holl, Reinhard W.
    Hougaard, P.
    Hansen, Lars
    Bjoerndalen, Hilde
    de Beaufort, Carine E.
    Knip, Michael
    PEDIATRIC DIABETES, 2010, 11 (04) : 218 - 226
1234